Japanese encephalitis
Therapeutic area
Infectious Disease
Rare disease
Yes
- Definition
- A disease due to a virus transmitted by an arthropod).
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- Yes
- Listing at source
- Listed
- Condition name
- Japanese encephalitis
- Therapeutic area
- Infectious Disease
- Japanese encephalitis
- Encephalitis, Japanese
- Japanese B encephalitis
- JE
- Severity
- Severe
- Acquired
- Inflammatory
- Infectious Disease
- Neurology
- MONDO ID
- MONDO:0019209
- Parent condition
- MONDO:0020601
Related records
Broader conditions (23)
- Acute disease
- Brain disorder
- Central nervous system disorder
- Central nervous system infectious disorder
- Disease
- Disease by body system or component
- Disease by developmental or physiological process
- Disease by etiologic mechanism
- Disease of primarily extrinsic mechanism
- Encephalitis
- Encephalomyelitis
- Human disease
- Infectious disease
- Infectious disorder of the nervous system
- Infectious encephalitis
- Inflammatory disease
- Mosquito-borne viral encephalitis
- Nervous system disorder
- Primary viral infectious disease
- Vector-borne disease
Trials (72)
- A Clinical Trial for Inactivated Japanese Encephalitis Vaccine in Healthy Chinese Infants
- A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults
- A Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2
- A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE and JE-VAX
- A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX
- A Study of ChimeriVax™-JE Live Attenuated Vaccine in Healthy Adults
- A Study of Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and Toddlers
- A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults
- An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity
- Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children
- Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine
- Clinical Evaluation of Insect Repellent and Insecticide Treated Nets in Lao PDR
- Clinical Trial to Assess the Immunogenicity and Safety of the Vero Cell-derived JE Vaccine in Korea
- Comparison of Three Batches of the Japanese Encephalitis Vaccine IC51
- Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51
- Concomitant Vaccination With the Japanese Encephalitis Vaccine IC51 and HARVIX® 1440
- Determining Long-Term Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine
- Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine
- Diagnostics and Surveillance of Acute Meningo-encephalitis Among Children in Cambodia With a Focus on Japanese Encephalitis Virus
- Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51
Approved drugs (1)
Drugs in development (4)
- Ribavirin Phase 2
- Rituximab Phase 2
- Satralizumab Phase 3
- Sodium chloride Phase 3